DESIGN, SYNTHESIS AND ANTICANCER ACTIVITY OF STRUCTURALLY MODIFIED 1, 3, 4-OXADIAZOLE INCORPORATED 2H-CHROMENE DERIVATIVES AS ANTICANCER AGENTS . Int. Res. J. Pharm. 2019, 10 (10), 87-92.